iCAD

Company Overview

iCAD’s Artificial Intelligence Solutions for Breast Healthcare are built on deep learning technology and deliver powerful software solutions for digital breast tomosynthesis (DBT), 2D mammography, breast density and risk assessment. These innovative solutions offer clinicians a wide range of tools for breast cancer detection that also enhance workflow and improve overall efficiency. 

Headquartered in Nashua, NH, iCAD® is a global medical technology leader providing innovative cancer detection and therapy solutions. For over 30 years, iCAD has been delivering transformative innovations, aimed to precisely and effectively detect cancer earlier, empowering clinicians to provide quality, cost-effective patient care.  

iCAD Inc. is renowned for its large multivendor compatibility, allowing seamless integration of their Breast Health Solutions into the diagnostic workflow. This commitment to interoperability enables healthcare providers to harness the power of AI in breast cancer detection without disrupting their existing imaging infrastructure, ultimately leading to improved patient care. 

Modalities